Recreation use of phosphodiesterase type 5 inhibitors, the other side of erectile dysfunction

被引：0
|
作者：
Fusco, Giovanni Maria [1 ]
Cirillo, Luigi [1 ]
Mastrangelo, Francesco [1 ]
Romano, Francesco [1 ]
di Mauro, Ernesto [1 ]
Cacace, Gianluigi [1 ]
Spena, Gianluca [1 ]
Iannicelli, Annamaria [2 ]
Franzese, Corrado Aniello [3 ]
Mirone, Vincenzo [1 ]
La Rocca, Roberto [1 ]
Napolitano, Luigi [1 ]
机构：
[1] Univ Naples Federico II, Dept Neurosci Reprod Sci & Odontostomatol, Urol Unit, Naples, Italy
[2] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
[3] ASL Napoli 3 Sud, Naples, Italy
来源：
ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA | 2023年 / 95卷 / 02期
关键词：
Erectile dysfunction; PDE5i; Recreational drug; YOUNG HEALTHY-MEN;
D O I：
10.4081/aiua.2023.11350
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：129 / 130
页数：2
相关论文
共 50 条
  • [41] A cost-utility analysis of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction
    Svenn Alexander Hansen
    Eline Aas
    Oddvar Solli
    [J]. The European Journal of Health Economics, 2020, 21 : 73 - 84
  • [42] Improvement in Endothelial Function in Men Taking Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction
    Konstantinovsky, Alex
    Kuchersky, Nina
    Kridin, Khalaf
    Blum, Arnon
    [J]. AMERICAN JOURNAL OF MEDICINE, 2023, 136 (10): : 1041 - 1043
  • [43] The management of erectile dysfunction in men with diabetes mellitus unresponsive to phosphodiesterase type 5 inhibitors
    Cayetano-Alcaraz, Axel Alberto
    Tharakan, Tharu
    Chen, Runzhi
    Sofikitis, Nikolaos
    Minhas, Suks
    [J]. ANDROLOGY, 2023, 11 (02) : 257 - 269
  • [44] Erectile dysfunction and dyslipidemia: Relevance and role of phosphodiesterase type-5 inhibitors and statins
    Miner, Martin
    Billups, Kevin L.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2008, 5 (05): : 1066 - 1078
  • [45] Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons
    Ferguson, James E., III
    Carson, Culley C., III
    [J]. ARAB JOURNAL OF UROLOGY, 2013, 11 (03) : 222 - 229
  • [46] IMPACT OF UNDIAGNOSED PREDIABETES ON PHOSPHODIESTERASE TYPE 5 INHIBITORS RESPONSE IN MEN WITH ERECTILE DYSFUNCTION
    Capogrosso, P.
    Boeri, L.
    Ventimiglia, E.
    Cazzaniga, W.
    Pozzi, E.
    Schifano, N.
    Chierigo, F.
    Abbate, C.
    Montanari, E.
    Montorsi, F.
    Salonia, A.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2019, 16 (05): : S52 - S53
  • [47] Alvage therapy trial for erectile dysfunction using phosphodiesterase type 5 inhibitors and vitamin
    Kondoh, Nobuyuki
    Higuchi, Yoshihide
    Maruyama, Takuo
    Nojima, Michio
    Yamamoto, Shingo
    Shima, Hiroki
    [J]. JOURNAL OF ANDROLOGY, 2007, : 81 - 81
  • [48] POSSIBLE FUTURE THERAPIES IN PATIENTS WITH ERECTILE DYSFUNCTION NOT RESPONDING TO PHOSPHODIESTERASE TYPE 5 INHIBITORS
    Driesen, K.
    Gonzalez Viedma, A.
    Hofkens, L.
    Philtjens, U.
    Brone, B.
    Sandner, P.
    Van Renterghem, K.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2020, 17 (06): : S159 - S160
  • [49] Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction
    Dunn, M. E.
    Althof, S. E.
    Perelman, M. A.
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (02) : 119 - 123
  • [50] Daily use of phosphodiesterase 5 inhibitors for erectile dysfunction and lower urinary tract symptoms
    H Pimentel
    M Wald
    C Niederberger
    [J]. International Journal of Impotence Research, 2008, 20 : 145 - 149
12345